Chemotherapy Induced Nausea and Vomiting
Chemotherapy SIG - The mission of the Chemotherapy Special Interest Group (SIG) is to promote excellence in the oncology nursing practice of chemotherapy administration and symptom management and to support the Oncology Nursing Society (ONS) mission statement.
CINV: Affecting Pathways, Optimizing Outcomes: Breakthrough, Delayed, Refractory CINV
0.9 Contact Hours
Expiration: 1/30/2009
This newsletter is supported by an unrestricted educational grant from Solvay Pharmaceuticals.
Here is the latest information about the management of breakthrough, delayed and refractory CINV written by clinical experts. This newsletter provides risk factor assessment and treatment information for this difficult condition. In addition, case studies are presented with questions and answers for an immediate understanding of how this information can be applied to specific situations.
Chemotherapy Induced Nausea and Vomiting (CINV) Clinical Resource Area
This resource area focuses on ways to minimize nausea and vomiting associated with chemotherapy. Prevention and control of nausea and vomiting is critical in the treatment of patients with cancer.